Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Clear all

459 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200024
200111
200219
200315
200414
200513
200628
200724
200820
200925
201015
201111
201212
201314
201413
201515
201620
201728
201819
201919
202023
202123
202210
20232
20245
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed459

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)35
GlaxoSmithKline11
Alliance for Clinical Trials in Oncology10
AstraZeneca10
Bristol-Myers Squibb10
Hoffmann-La Roche10
AbbVie9
Eli Lilly and Company7
Memorial Sloan Kettering Cancer Center7
Celgene6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma459
Carcinoma, Non-Small-Cell Lung175
Lung Neoplasms161
Breast Neoplasms66
Pancreatic Neoplasms48
Ovarian Neoplasms47
Stomach Neoplasms47
Neoplasms41
Head and Neck Neoplasms39
Esophageal Neoplasms38

Trials

Showing 26 to 50 of 459. Each trial links to its page on Pharma Observatory.

359 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.